Technical note: The calculated real world BNT162b2 vaccine efficacy was 88% when accounting for asymptomatic cases
- PMID: 35213948
- PMCID: PMC8903997
- DOI: 10.1080/21645515.2021.1994800
Technical note: The calculated real world BNT162b2 vaccine efficacy was 88% when accounting for asymptomatic cases
Abstract
COVID-19 trials have relied on symptomatic subjects for judging the effectiveness of vaccine candidates, whereas asy-mptomatic subjects have been suspected as the main driver of the pandemic. An assumption of the same impact on symptomatic and asymptomatic breakthrough infections is shown to be flawed, resulting in an overestimate of the vaccines' true effectiveness. Recent available data provide the first large-scale unbiased data on asymptomatic versus symptomatic infections postvaccination, providing a unique opportunity to reassess the true infection rates after vaccination. By this, the breakthrough of the BNT162b2 vaccine is seen to be 12% rather than 5% for a corrected overall efficiency (symptomatic + asymptomatic) of 88% with the original virus strain in a real-world setting.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Comment on
-
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152. JAMA. 2021. PMID: 33956048 Free PMC article.
References
-
- Vignier N, Bérot V, Bonnave N, Peugny S, Ballet M, Jacoud E, Michaud C, Gaillet M, Djossou F, Blanchet D, et al. Breakthrough infections of SARS-CoV-2 Gamma variant in fully vaccinated gold miners, French Guiana, 2021. Emerg Infect Dis. 2021. Oct;27(10):2673–76. doi:10.3201/eid2710.211427. - DOI - PMC - PubMed
-
- Luo CH, Morris CP, Sachithanandham J, Amadi A, Gaston D, Li M, Swanson NJ, Schwartz M, Klein EY, Pekosz A, Mostafa HH . Infection with the SARS-CoV-2 delta variant is associated with higher infectious virus loads compared to the alpha variant in both unvaccinated and vaccinated individuals. medRxiv. 2021. Aug 20. 2021.08.15.21262077. doi:10.1101/2021.08.15.21262077. - DOI - PMC - PubMed
-
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. C4591001 Clinical Trial Group . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020. Dec 31;383(27):2603–15. doi:10.1056/NEJMoa2034577. - DOI - PMC - PubMed
-
- Miron D, Lavi I, Kitov R, Hendler A.. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J. 2005. Mar;24(3):233–36. PMID: 15750459. doi:10.1097/01.inf.0000154323.20387.82. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical